| Primary |
| Cellulitis |
15.4% |
| Pharyngitis |
15.4% |
| Arthropathy |
7.7% |
| Gastritis |
7.7% |
| Nasopharyngitis |
7.7% |
| Pain |
7.7% |
| Pharyngitis Streptococcal |
7.7% |
| Product Used For Unknown Indication |
7.7% |
| Pyrexia |
7.7% |
| Tooth Infection |
7.7% |
| Upper Respiratory Tract Infection |
7.7% |
|
| Toxic Epidermal Necrolysis |
12.5% |
| Angioedema |
6.3% |
| Dysgeusia |
6.3% |
| Face Oedema |
6.3% |
| Generalised Oedema |
6.3% |
| Hypersensitivity |
6.3% |
| Jaundice |
6.3% |
| Mucosal Erosion |
6.3% |
| Pancreatic Duct Dilatation |
6.3% |
| Pigmentation Disorder |
6.3% |
| Premature Separation Of Placenta |
6.3% |
| Septic Shock |
6.3% |
| Swelling Face |
6.3% |
| Urticaria |
6.3% |
| Vulvovaginal Discomfort |
6.3% |
|
| Secondary |
| Product Used For Unknown Indication |
46.2% |
| Tonsillitis |
8.1% |
| Infection Prophylaxis |
5.4% |
| Multiple Myeloma |
4.5% |
| Pyrexia |
4.5% |
| Prophylaxis Against Transplant Rejection |
4.1% |
| Cellulitis |
3.6% |
| Graft Versus Host Disease |
2.7% |
| Prophylaxis |
2.7% |
| Gout |
2.3% |
| Cardiac Failure |
1.8% |
| Cytomegalovirus Infection |
1.8% |
| Dermatitis |
1.8% |
| Hypothyroidism |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
| Adenovirus Infection |
1.4% |
| Chronic Lymphocytic Leukaemia |
1.4% |
| Ill-defined Disorder |
1.4% |
| Pharyngitis |
1.4% |
| Tonsillitis Streptococcal |
1.4% |
|
| Myocardial Infarction |
11.4% |
| Blindness Transient |
8.6% |
| Headache |
8.6% |
| Vomiting |
8.6% |
| Livedo Reticularis |
5.7% |
| Persistent Foetal Circulation |
5.7% |
| Rash Papular |
5.7% |
| Swelling |
5.7% |
| Viral Infection |
5.7% |
| Wheezing |
5.7% |
| Acute Myocardial Infarction |
2.9% |
| Angioedema |
2.9% |
| Chromaturia |
2.9% |
| Clostridium Difficile Colitis |
2.9% |
| Dehydration |
2.9% |
| Diarrhoea |
2.9% |
| Drug Interaction |
2.9% |
| Dry Skin |
2.9% |
| Epigastric Discomfort |
2.9% |
| Erysipelas |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.4% |
| Multiple Myeloma |
10.4% |
| Drug Use For Unknown Indication |
9.4% |
| Prophylaxis |
7.5% |
| Pain |
5.4% |
| Infection Prophylaxis |
5.1% |
| Hypertension |
3.7% |
| Bronchitis |
3.2% |
| Graft Versus Host Disease |
3.1% |
| Arthritis Bacterial |
2.7% |
| Diabetes Mellitus |
2.6% |
| Stem Cell Transplant |
2.6% |
| Acute Lymphocytic Leukaemia |
2.4% |
| Nausea |
2.3% |
| Prophylaxis Against Graft Versus Host Disease |
2.1% |
| Schizophrenia |
2.1% |
| Chronic Lymphocytic Leukaemia |
1.9% |
| Nephrotic Syndrome |
1.9% |
| Hypercholesterolaemia |
1.7% |
| Depression |
1.6% |
|
| Rhabdomyolysis |
14.8% |
| Weight Decreased |
14.1% |
| Ventricular Dysfunction |
12.5% |
| Vomiting |
8.6% |
| Weight Increased |
5.5% |
| Pulmonary Embolism |
3.9% |
| Renal Impairment |
3.9% |
| Sarcoidosis |
3.9% |
| Benign Intracranial Hypertension |
3.1% |
| Fatigue |
3.1% |
| Hypotension |
3.1% |
| Tongue Discolouration |
3.1% |
| Urticaria |
3.1% |
| Wrong Technique In Drug Usage Process |
3.1% |
| Chest Pain |
2.3% |
| Confusional State |
2.3% |
| Hypokinesia |
2.3% |
| Incoherent |
2.3% |
| Intraventricular Haemorrhage |
2.3% |
| Lethargy |
2.3% |
|
| Interacting |
|
|
